Javascript is disabled or is not supported by your browser. Please upgrade your browser or enable Javascript to navigate the interface properly.

Diadema Partners

Latest statistics and disclosures from Diadema Partners's latest quarterly 13F-HR filing:

Top 5 stock holdings are VKTX, VRTX, BBIO, XBI, PRAX, and represent 31.57% of Diadema Partners's stock portfolio.
Added to shares of these 10 stocks: VRTX (+$45M), XBI (+$31M), VKTX (+$26M), JNJ (+$24M), BBIO (+$21M), QQQ (+$18M), GPCR (+$13M), CAPR (+$11M), INSM (+$9.2M), CORT (+$7.2M).
Started 46 new stock positions in EWTX, BCRX, MLYS, XBI, QQQ, INSM, VRTX, JNJ, IVA, BIOA.
Reduced shares in these 10 stocks: BMY (-$14M), , JAZZ (-$12M), REGN (-$12M), SLNO (-$12M), HRMY (-$9.1M), PCVX (-$9.0M), AGIO (-$8.9M), LLY (-$8.6M), COGT (-$5.9M).
Sold out of its positions in ACAD, AGIO, ALEC, FOLD, AMLX, ANAB, ARCT, AUPH, RCEL, BMY.
Diadema Partners was a net buyer of stock by $98M.
Diadema Partners has $581M in assets under management (AUM), dropping by 48.49%.
Central Index Key (CIK): 0002026172

Tip: Access up to 7 years of quarterly data

Positions held by Diadema Partners consolidated in one spreadsheet with up to 7 years of data

Download as csv

Download as Excel

Portfolio Holdings for Diadema Partners

Diadema Partners holds 119 positions in its portfolio as reported in the December 2025 quarterly 13F filing

Company (Ticker)	Portfolio Weight	Valued At	Change in Shares	Share Count	Share Price
Viking Therapeutics (VKTX)	8.1	$47M	+124%	1.3M	35.18	View chart
Vertex Pharmaceuticals Incorporated (VRTX)	7.7	$45M	NEW	98k	453.36	View chart
Bridgebio Pharma (BBIO)	5.4	$31M	+211%	410k	76.49	View chart
Spdr Series Trust State Street Spd Put Option (XBI)	5.3	$31M	NEW	250k	121.93	View chart
Praxis Precision Medicines I Com New Put Option (PRAX)	5.1	$30M		101k	294.74	View chart
Johnson & Johnson (JNJ)	4.2	$24M	NEW	116k	206.95	View chart
Avidity Biosciences Ord Call Option (RNA)	4.1	$24M	+42%	328k	72.13	View chart
Capricor Therapeutics Com New (CAPR)	3.3	$19M	+123%	670k	28.86	View chart
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)	3.2	$18M	NEW	30k	614.31	View chart
Jazz Pharmaceuticals Shs Usd Call Option (JAZZ)	3.1	$18M	-39%	105k	170.00	View chart
Terns Pharmaceuticals (TERN)	2.9	$17M	-25%	411k	40.40	View chart
Apogee Therapeutics Call Option (APGE)	2.7	$16M	+10%	211k	75.48	View chart
Structure Therapeutics Sponsored Ads Call Option (GPCR)	2.3	$13M	NEW	192k	69.55	View chart
Regeneron Pharmaceuticals (REGN)	2.0	$12M	-49%	15k	771.87	View chart
Abivax Sa Sponsored Ads (ABVX)	1.8	$10M	+81%	76k	134.85	View chart
Incyte Corporation Put Option (INCY)	1.7	$9.9M		100k	98.77	View chart
Insmed Com Par $.01 Call Option (INSM)	1.6	$9.2M	NEW	53k	174.04	View chart
BioMarin Pharmaceutical (BMRN)	1.5	$8.7M	-31%	146k	59.43	View chart
Indivior Ord	1.5	$8.5M	-6%	238k	35.88	View chart
Ionis Pharmaceuticals Call Option (IONS)	1.4	$8.4M	+6%	106k	79.11	View chart
Uniqure Nv SHS (QURE)	1.4	$8.3M	+15%	347k	23.93	View chart
Corcept Therapeutics Incorporated (CORT)	1.4	$8.1M	+776%	232k	34.80	View chart
Roivant Sciences SHS Put Option (ROIV)	1.2	$6.9M	-24%	319k	21.70	View chart
Zymeworks Del Call Option (ZYME)	1.2	$6.9M	+33%	262k	26.33	View chart
Tg Therapeutics (TGTX)	1.1	$6.7M	+267%	223k	29.81	View chart
Ocular Therapeutix Call Option (OCUL)	1.1	$6.6M	+298%	545k	12.14	View chart
Crispr Therapeutics Namen Akt Call Option (CRSP)	1.0	$5.9M		113k	52.44	View chart
United Therapeutics Corporation (UTHR)	0.8	$4.9M	NEW	10k	487.25	View chart
Mannkind Corp Com New (MNKD)	0.8	$4.8M	-31%	854k	5.67	View chart
Intellia Therapeutics Call Option (NTLA)	0.8	$4.8M	+12%	529k	8.99	View chart
Cogent Biosciences (COGT)	0.8	$4.7M	-55%	132k	35.52	View chart
Biosante Pharmaceuticals (ANIP)	0.7	$4.2M	+69%	53k	78.94	View chart
Bioage Labs (BIOA)	0.7	$3.9M	NEW	294k	13.23	View chart
Soleno Therapeutics (SLNO)	0.6	$3.7M	-75%	80k	46.30	View chart
Aquestive Therapeutics Call Option (AQST)	0.6	$3.5M	NEW	549k	6.46	View chart
Annexon (ANNX)	0.6	$3.3M	NEW	659k	5.02	View chart
Recursion Pharmaceuticals In Cl A Call Option (RXRX)	0.5	$3.0M	+6%	742k	4.09	View chart
Tenax Therapeutics Com New (TENX)	0.5	$3.0M	NEW	243k	12.19	View chart
Revolution Medicines (RVMD)	0.5	$2.9M	-37%	37k	79.65	View chart
Centessa Pharmaceuticals Sponsored Ads (CNTA)	0.5	$2.8M	NEW	111k	25.01	View chart
Gossamer Bio Call Option (GOSS)	0.5	$2.7M	+6%	877k	3.10	View chart
Novo-nordisk A S Adr Put Option (NVO)	0.5	$2.7M	-57%	53k	50.88	View chart
Arbutus Biopharma Call Option (ABUS)	0.5	$2.6M	+6%	549k	4.81	View chart
Immunocore Hldgs Ads (IMCR)	0.4	$2.4M	-43%	70k	34.71	View chart
Olema Pharmaceuticals Call Option (OLMA)	0.4	$2.4M	+6%	96k	25.00	View chart
Ironwood Pharmaceuticals Com Cl A (IRWD)	0.4	$2.3M	NEW	684k	3.37	View chart
Ultragenyx Pharmaceutical Call Option (RARE)	0.4	$2.3M	-64%	100k	23.00	View chart
Biohaven Call Option (BHVN)	0.4	$2.3M	NEW	200k	11.29	View chart
Replimune Group (REPL)	0.4	$2.2M	-62%	231k	9.72	View chart
Eli Lilly & Co. (LLY)	0.4	$2.1M	-80%	2.0k	1074.68	View chart
Alnylam Pharmaceuticals (ALNY)	0.4	$2.1M	-46%	5.3k	397.65	View chart
Tectonic Therapeutic Call Option (TECX)	0.4	$2.1M		101k	20.86	View chart
Lipocine Com New (LPCN)	0.4	$2.1M	NEW	261k	8.03	View chart
Protagonist Therapeutics (PTGX)	0.3	$2.0M	-55%	23k	87.34	View chart
Travere Therapeutics Put Option (TVTX)	0.3	$1.9M	+16666%	50k	38.21	View chart
Relmada Therapeutics (RLMD)	0.3	$1.9M	NEW	389k	4.83	View chart
Cormedix Inc cormedix Put Option (CRMD)	0.3	$1.8M	+59%	159k	11.63	View chart
Ventyx Biosciences (VTYX)	0.3	$1.8M	+180%	200k	9.03	View chart
Altimmune Com New Call Option (ALT)	0.3	$1.8M	+6%	492k	3.61	View chart
Vanda Pharmaceuticals Call Option (VNDA)	0.3	$1.8M	NEW	200k	8.82	View chart
Sellas Life Sciences Group I Com New Call Option (SLS)	0.3	$1.6M	+6%	425k	3.77	View chart
Inventiva Sa Ads (IVA)	0.3	$1.6M	NEW	334k	4.65	View chart
Legend Biotech Corp Sponsored Ads Call Option (LEGN)	0.3	$1.5M	NEW	69k	21.74	View chart
BioCryst Pharmaceuticals (BCRX)	0.3	$1.5M	NEW	191k	7.80	View chart
Ardelyx (ARDX)	0.3	$1.5M	-36%	252k	5.83	View chart
Ascendis Pharma A/s Sponsored Adr (ASND)	0.3	$1.5M	-75%	6.8k	213.24	View chart
Xeris Pharmaceuticals (XERS)	0.2	$1.3M	+128%	171k	7.85	View chart
Rigel Pharmaceuticals (RIGL)	0.2	$1.3M	NEW	30k	42.83	View chart
Pacira Pharmaceuticals (PCRX)	0.2	$1.2M	-18%	48k	25.88	View chart
Trevi Therapeutics (TRVI)	0.2	$1.2M	+13%	97k	12.52	View chart
Vir Biotechnology (VIR)	0.2	$1.1M	NEW	189k	6.03	View chart
Maplight Therapeutics (MPLT)	0.2	$1.1M	NEW	64k	17.57	View chart
Inovio Pharmaceuticals Com Shs (INO)	0.2	$1.1M	NEW	634k	1.74	View chart
Vaxcyte (PCVX)	0.2	$1.1M	-89%	23k	46.14	View chart
Enanta Pharmaceuticals (ENTA)	0.2	$1.0M	NEW	65k	15.77	View chart
Prothena Corp SHS (PRTA)	0.2	$1.0M	NEW	107k	9.55	View chart
Monte Rosa Therapeutics (GLUE)	0.2	$977k	NEW	62k	15.68	View chart
Design Therapeutics (DSGN)	0.2	$941k	NEW	100k	9.38	View chart
Mineralys Therapeutics (MLYS)	0.2	$907k	NEW	25k	36.29	View chart
Mereo Biopharma Group Spon Ads Call Option (MREO)	0.1	$833k	+28%	2.0M	0.42	View chart
Kodiak Sciences Call Option (KOD)	0.1	$828k	+2%	30k	27.96	View chart
Aytu Biopharma (AYTU)	0.1	$795k	+12%	306k	2.60	View chart
Evolus Call Option (EOLS)	0.1	$790k	NEW	119k	6.65	View chart
Pelthos Therapeutics Com Shs (PTHS)	0.1	$775k	+138%	25k	31.00	View chart
Liquidia Corporation Com New (LQDA)	0.1	$755k	NEW	22k	34.49	View chart
Edgewise Therapeutics (EWTX)	0.1	$745k	NEW	30k	24.82	View chart
Miragen Therapeutics (VRDN)	0.1	$657k	NEW	21k	31.12	View chart
Editas Medicine Call Option (EDIT)	0.1	$653k	+6%	319k	2.05	View chart
Moonlake Immunotherapeutics Class A Ord Call Option (MLTX)	0.1	$622k	+80%	47k	13.18	View chart
Ligand Pharmaceuticals Com New (LGND)	0.1	$565k	NEW	3.0k	189.07	View chart
Upstream Bio (UPB)	0.1	$557k	-89%	21k	27.15	View chart
Stoke Therapeutics (STOK)	0.1	$545k	NEW	17k	31.74	View chart
Equillium (EQ)	0.1	$539k	+15%	347k	1.55	View chart
Urogen Pharma (URGN)	0.1	$511k	-75%	22k	23.42	View chart
Anavex Life Sciences Corp Com New Call Option (AVXL)	0.1	$501k		141k	3.56	View chart
Immunome (IMNM)	0.1	$483k	NEW	23k	21.48	View chart
Black Diamond Therapeutics Call Option (BDTX)	0.1	$463k	NEW	190k	2.43	View chart
Janux Therapeutics Call Option (JANX)	0.1	$414k	NEW	30k	13.80	View chart
Corvus Pharmaceuticals Put Option (CRVS)	0.1	$409k	+6%	53k	7.70	View chart
Palisade Bio (PALI)	0.1	$390k	NEW	166k	2.35	View chart
Proqr Thrapeutics N V Shs Euro (PRQR)	0.1	$338k	+6%	168k	2.02	View chart
Harmony Biosciences Hldgs In (HRMY)	0.0	$281k	-97%	7.5k	37.42	View chart
Aardvark Therapeutics (AARD)	0.0	$209k	NEW	16k	13.12	View chart
Puma Biotechnology Call Option (PBYI)	0.0	$201k	-75%	34k	5.95	View chart
Neuphoria Therapeutics (NEUP)	0.0	$194k	+133%	50k	3.88	View chart
Pliant Therapeutics (PLRX)	0.0	$177k	NEW	145k	1.22	View chart
Beone Medicines Sponsored Ads (ONC)	0.0	$173k	NEW	7.5k	23.04	View chart
Foghorn Therapeutics (FHTX)	0.0	$165k	-38%	31k	5.40	View chart
Talphera Com New (TLPH)	0.0	$156k	NEW	137k	1.14	View chart
Reviva Pharmaceutcls Hldgs I Call Option (RVPH)	0.0	$140k	-80%	500k	0.28	View chart
Vistagen Therapeutics Ord (VTGN)	0.0	$137k	-54%	207k	0.66	View chart
Puretech Health Ads (PRTC)	0.0	$124k		7.4k	16.64	View chart
Lyell Immunopharma Com New Put Option (LYEL)	0.0	$117k	NEW	3.8k	30.78	View chart
Inhibrx Biosciences (INBX)	0.0	$103k	NEW	1.3k	79.00	View chart
Edesa Biotech Com New (EDSA)	0.0	$77k	NEW	54k	1.42	View chart
Atyr Pharma Com New Put Option (ATYR)	0.0	$21k	-86%	27k	0.78	View chart
Cassava Sciences Put Option (SAVA)	0.0	$21k	+7%	11k	1.98	View chart
Jade Biosciences Com New Put Option (JBIO)	0.0	$3.0k		1.0k	2.84	View chart
Applied Therapeutics Call Option	0.0	$2.0k	+6%	20k	0.10	View chart

Past Filings by Diadema Partners

SEC 13F filings are viewable for Diadema Partners going back to 2025

Diadema Partners 2025 Q4 filed Feb. 17, 2026
Diadema Partners 2025 Q3 filed Nov. 14, 2025

Disclaimers: stockzoa.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on stockzoa.com represent a recommendation to purchase or sell a stock. The information on this site is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall stockzoa.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content available on stockzoa.com, or relating to the use of, or inability to use, stockzoa.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.

Fund Directory: 1-9 A B C D E F G H I J K L M N O P Q R S T U V W X-Z